Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.
about
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Second-generation Flagellin-rPAc Fusion Protein, KFD2-rPAc, Shows High Protective Efficacy against Dental Caries with Low Potential Side Effects.DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.Safety and Immunogenicity of an Egg-Cultivated Quadrivalent Inactivated Split-virion Influenza Vaccine (GC3110A) in Healthy Korean Children: a Randomized, Double-blinded, Active-controlled Phase III Study.
P2860
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@ast
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@en
type
label
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@ast
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@en
prefLabel
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@ast
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@en
P2093
P2860
P356
P1476
Phase 1 Safety and Immunogenic ...... nin-Flagellin Fusion Proteins.
@en
P2093
C Jo White
Casey Johnson
Cynthia Strout
Gregg Lucksinger
Katalin Abraham
Langzhou Song
Lynda Tussey
Matthew Davis
Scott Umlauf
P2860
P304
P356
10.1093/OFID/OFW015
P577
2016-01-29T00:00:00Z